Detalhe da pesquisa
1.
Cost-effectiveness of acromegaly treatments: a systematic review.
Pituitary
; 21(6): 642-652, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30159696
2.
Efficacy and safety of drugs for attention deficit hyperactivity disorder in children and adolescents: a network meta-analysis.
Eur Child Adolesc Psychiatry
; 27(10): 1335-1345, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29460165
3.
Ledipasvir/sofosbuvir with or without ribavirin for the treatment of chronic hepatitis C genotype 1: A pairwise meta-analysis.
J Gastroenterol Hepatol
; 32(4): 749-755, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27785825
4.
Efficacy and safety of amphotericin B lipid-based formulations-A systematic review and meta-analysis.
Mycoses
; 60(3): 146-154, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27878878
5.
Cost-Effectiveness of Molecular Method Diagnostic for Rapid Detection of Antibiotic-Resistant Bacteria.
Value Health Reg Issues
; 27: 12-20, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34784543
6.
Safety of Antiretroviral Therapy in the Treatment of HIV/AIDS in Children: Systematic Review and Meta-analysis.
AIDS Rev
; 23(4): 196-203, 2021 12 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34082441
7.
Analysis of completeness for spontaneous reporting of disease-modifying therapies in multiple sclerosis.
Expert Opin Drug Saf
; 20(6): 735-740, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33641547
8.
Newborn Screening for the Detection of the TP53 R337H Variant and Surveillance for Early Diagnosis of Pediatric Adrenocortical Tumors: Lessons Learned and Way Forward.
Cancers (Basel)
; 13(23)2021 Dec 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34885220
9.
Effectiveness and Cost-Effectiveness of Triple Therapy With Telaprevir and Boceprevir for Chronic Hepatitis C: A Decision Analysis From the Brazilian Public Health System Perspective.
Value Health Reg Issues
; 20: 95-102, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31108456
10.
Safety of Biologics Approved for the Treatment of Rheumatoid Arthritis and Other Autoimmune Diseases: A Disproportionality Analysis from the FDA Adverse Event Reporting System (FAERS).
BioDrugs
; 32(4): 377-390, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29873000
11.
Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: A Network Meta-Analysis.
CNS Drugs
; 32(9): 813-826, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30014314